- Central Florida Division External Communications
Patients with severe cases of COVID-19 may find help in an unlikely source – the blood plasma of patients who’ve recovered from the disease.
It’s called convalescent plasma, and the idea is that antibodies in the donated plasma will help fight the disease in patients who are suffering through it.
“This is an extremely exciting development that shows promise in helping our sickest patients,” said Dr. Juliana Gaitan, who is leading the project. “We’re among the first hospitals in the country to begin offering this therapy.”
The U.S. Food & Drug Administration is facilitating access to the COVID-19 convalescent plasma for use in patients with serious or immediately life-threatening infections.
AdventHealth is working with OneBlood to solicit donations from recovered patients across the region. OneBlood will collect the plasma, which can be collected either from whole-blood or plasma-only donors.
Recovered patients who are at least 15 days out from experiencing symptoms are eligible to donate.
“We are really depending on the community for support,” said Dr. Gaitan. “As the number of COVID-19 cases increases, we expect high demand for this potentially lifesaving treatment.”
Prospective donors can get more information here:
https://www.oneblood.org/lp/covid-19-convalescent-plasma.stml#btndonate
Recent News
The holiday season can increase heart attack risks due to overindulgence, stress and ignored symptoms, but there are ways to mitigate these risks.
David Weis has been promoted to serve as president/CEO for the region covering east Volusia, Flagler and St. Johns counties. Lorenzo Brown has been promoted to serve as president/CEO for the region...
On the newest Inspiring Wholeness podcast, Obie Diaz, local morning radio show host, shares how a routine physical eventually led to two open heart surgeries.
AdventHealth President and CEO Terry Shaw has been named one of Modern Healthcare’s 100 Most Influential People in Healthcare for 2024, marking continued recognition of Shaw as a transformative leader...
AdventHealth President/CEO Terry Shaw's retirement is planned for July 2025.
AdventHealth has named Elise MacCarroll-Wright as president and CEO of UChicago Medicine AdventHealth Hinsdale in its Great Lakes Region, effective Jan. 6, 2025.
AdventHealth has named Dave Tkachuck president/CEO for UChicago Medicine AdventHealth La Grange, effective Jan. 6.
A UChicago Medicine AdventHealth neurologist addresses the growing gap between the number of men and women diagnosed with MS.
AdventHealth has named Ryan Quattlebaum president/CEO for AdventHealth Wesley Chapel, effective Dec. 29.
Health care and government leaders celebrate the much-anticipated expansion of AdventHealth University.
Wangsness has more than 30 years of experience in health care.